Johnson & Johnson - Database of Clinical Trials by Pharmaceutical Companies

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Johnson & Johnson

Top of Directory » All Categories » by Company » Johnson & Johnson



  • Effectiveness and Safety of Flexible Doses of Paliperidone Prolonged Release in Adolescent Patients With Schizophrenia

    Condition:   Schizophrenia
    Interventions:   Drug: Aripiprazole;   Drug: Paliperidone PR
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Not yet recruiting - verified November 2009
  • [Trial of device that is not approved or cleared by the U.S. FDA]

    Condition:  
    Intervention:  
    Sponsor:   Johnson & Johnson Consumer & Personal Products Worldwide
    Withheld
  • An Exploratory Study to Assess the Effects of JNJ-39439335 on the Relief of Pain Using a Thermal-Grill Experimental Model

    Condition:   Pain
    Intervention:   Drug: JNJ-39439335, Placebo
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Not yet recruiting - verified November 2009
  • Diabetes Group Visits

    Condition:   Diabetes
    Intervention:  
    Sponsors:   Emory University;   Johnson & Johnson;   American Association of Diabetes Educators
    Enrolling by invitation - verified November 2009
  • OTIS Autoimmune Diseases in Pregnancy Project

    Conditions:   Ankylosing Spondylitis;   Psoriatic Arthritis;   Psoriasis;   Rheumatoid Arthritis
    Intervention:  
    Sponsors:   University of California, San Diego;   Organization of Teratology Information Specialists (OTIS);   Amgen
    Recruiting - verified November 2009
  • RCT for the Treatment of Acute Asthma in Wheezy Pre-school Aged Children

    Condition:   Asthma
    Interventions:   Drug: Azithromycin;   Drug: Placebo
    Sponsor:   Alberta Children's Hospital
    Not yet recruiting - verified November 2009
  • Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia

    Conditions:   Smoking Cessation;   Schizophrenia
    Intervention:   Drug: Nicotine Nasal Spray
    Sponsors:   University of Medicine and Dentistry New Jersey;   National Institute on Drug Abuse (NIDA)
    Active, not recruiting - verified November 2009
  • Tetradecanoylphorbol Acetate, Dexamethasone, and Choline Magnesium Trisalicylate in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    Condition:   Leukemia
    Interventions:   Drug: choline magnesium trisalicylate;   Drug: dexamethasone;   Drug: tetradecanoylphorbol acetate;   Other: laboratory biomarker analysis
    Sponsors:   Cancer Institute of New Jersey;   National Cancer Institute (NCI)
    Recruiting - verified October 2009
  • Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation

    Condition:   Heart Failure
    Intervention:  
    Sponsor:   Cardiac Concepts, Inc.
    Recruiting - verified November 2009
  • Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

    Condition:   Colorectal Cancer
    Interventions:   Biological: bevacizumab;   Drug: XELOX regimen;   Drug: capecitabine;   Drug: hydroxychloroquine;   Drug: oxaliplatin;   Other: laboratory biomarker analysis
    Sponsors:   Cancer Institute of New Jersey;   National Cancer Institute (NCI)
    Recruiting - verified August 2009
  • Interdisciplinary Mobility Team Approach To Reduction Of Facility-Acquired Pressure Ulcers

    Condition:   Pressure Ulcers
    Interventions:   Other: Pressure Ulcer Prevention;   Other: Pressure Ulcer Prevention;   Other: Reduction of Pressure Ulcers;   Other: Reduction of Pressure Ulcers;   Other: Reduction of Pressure Ulcers;   Other: Reduction of Pressure Ulcers;   Other: Reduction of Pressure Ulcers;   Other: Reduction of Pressure Ulcers;   Other: Reduction of Pressure Ulcers;   Other: Reduction of Pressure Ulcers
    Sponsors:   University of Cincinnati;   Robert Wood Johnson Foundation
    Completed - verified November 2009
  • CoreValve® System Australia/New Zealand Clinical Study

    Condition:   Aortic Valve Stenosis
    Intervention:   Device: Medtronic CoreValve® System
    Sponsors:   Medtronic Heart Valves;   Medtronic Vascular;   Medtronic Australasia
    Recruiting - verified November 2009
  • Joint Outcome Study Continuation for Children With Severe Factor VIII Deficiency

    Condition:   Hemophilia
    Intervention:  
    Sponsors:   University of Colorado at Denver and Health Sciences Center;   Bayer;   Rush University Medical Center;   Phoenix Children's Hospital;   The University of Texas Health Science Center, Houston;   Oregon Health and Science University;   Emory University;   University of Texas Southwestern Medical Center;   Palmetto Health Richland;   Indiana University School of Medicine;   Intermountain Health Care, Inc.
    Enrolling by invitation - verified October 2009
    • Menu
    Find Paid Clinical Trials